Form 4: Denali Therapeutics CFO Alexander O. Schuth Executes Stock Option and Sells Shares
SEC Form 4 Filing
Alexander O. Schuth, CFO of Denali Therapeutics, exercised stock options and sold shares under a pre-arranged 10b5-1 trading plan.
Summary
- On November 7, 2024, Alexander O. Schuth, the CFO and Secretary of Denali Therapeutics Inc., exercised a stock option to acquire 15,558 shares of common stock at a price of $5.28 per share.
- Following the exercise of the option, Schuth sold a total of 15,558 shares in multiple transactions at weighted average prices ranging from $29.68 to $31.29.
- These sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on September 29, 2023.
- After these transactions, Schuth directly owns 178,066 shares of Denali Therapeutics common stock and indirectly owns 523,749 shares through The Schuth Family Trust.
- The direct holdings include 118,810 unvested Restricted Stock Units (RSUs).
Sentiment
Score: 5
Explanation: This is a routine regulatory filing related to insider trading activity. The sentiment is neutral as it simply reports transactions.
Industry Context
Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the transactions of company insiders. The use of 10b5-1 plans is a common practice to allow insiders to sell shares without being accused of trading on non-public information.
Key Dates
| Date | Description |
|---|---|
| 03/07/2027 | Expiration date of the stock option |
| 06/05/2017 | Date of The Schuth Family Trust |
| 09/29/2023 | Date of adoption of Rule 10b5-1 trading plan |
| 11/07/2024 | Date of stock option exercise and share sales |
| 11/12/2024 | Date of signature on the Form 4 |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.